The pharmacokinetics and pharmacodynamics of trimazosin are described following both intravenous and oral administration to 6 normotensive, male volunteers. The IV and oral drug and metabolite (l-hydroxytrimazosin) concentration data are fitted simultaneously to the same pharmacokinetic model. The p
Pharmacokinetic–pharmacodynamic model for the anticholinergic effect of glycopyrrolate
✍ Scribed by Jani Penttilä; Antti Helminen; Kirsti Luomala; Harry Scheinin
- Publisher
- Springer
- Year
- 2001
- Tongue
- English
- Weight
- 133 KB
- Volume
- 57
- Category
- Article
- ISSN
- 0031-6970
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
A pharmacokinetic (PK)/pharmacodynamic (PD) modeling strategy to simulate in vivo bactericidal effects for three carbapenem antibiotics, doripenem (DRPM), meropenem (MEPM)/cilastatin (CS), and imipenem (IPM)/CS, against a Pseudomonas aeruginosa (P. aeruginosa) strain is proposed. The PD model we hav
A pharmacokinetic (PK)/pharmacodynamic (PD) modeling strategy to explain the data from an in vitro dynamic model is proposed. Two carbapenem antibiotics, doripenem and meropenem, and three Pseudomonas aeruginosa strains were used as example drugs and strains. The PD model we originally developed to